Soluble angiotensin-converting enzyme 2 association with lipid metabolism
Increased expression of angiotensin-converting enzyme 2 (ACE2) is one of the likely explanations for disease severity in patients with coronavirus disease 2019 (COVID-19). In this study, we aimed to test whether soluble ACE2 (sACE2) levels are correlated to known risk factors of severe COVID-19 incl...
Main Authors: | Izumi Nagatomo, Kaori Nakanishi, Ryohei Yamamoto, Seiko Ide, Chisaki Ishibashi, Toshiki Moriyama, Keiko Yamauchi-Takihara |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.955928/full |
Similar Items
-
Soluble Angiotensin Converting Enzyme 2 (ACE2) Is Upregulated and Soluble Endothelial Nitric Oxide Synthase (eNOS) Is Downregulated in COVID-19-induced Acute Respiratory Distress Syndrome (ARDS)
by: Alice G. Vassiliou, et al.
Published: (2021-07-01) -
Association of secondhand smoke exposure and health-related lifestyle behaviors among male university employees in Japan
by: Kaori Nakanishi, et al.
Published: (2023-09-01) -
Serum FGF21 levels are altered by various factors including lifestyle behaviors in male subjects
by: Kaori Nakanishi, et al.
Published: (2021-11-01) -
Profiling Levels of Serum microRNAs and Soluble ACE2 in COVID-19 Patients
by: Noha Mousaad Elemam, et al.
Published: (2022-04-01) -
Serum angiotensin converting enzyme, Erythrocyte sedimentation rate and high sensitive-C reactive protein levels in diagnosis of cardiac sarcoidosis- where do we stand?
by: Debabrata Bera, et al.
Published: (2020-09-01)